Selected article for: "drug target and RNA binding"

Author: Lee, Hyunjong; Park, Jeongbin; Im, Hyung-Jun; Na, Kwon Joong; Choi, Hongyoon
Title: Discovery of potential imaging and therapeutic targets for severe inflammation in COVID-19 patients
  • Cord-id: g3tdt306
  • Document date: 2021_7_8
  • ID: g3tdt306
    Snippet: The Coronavirus disease 2019 (COVID-19) has been spreading worldwide with rapidly increased number of deaths. Hyperinflammation mediated by dysregulated monocyte/macrophage function is considered to be the key factor that triggers severe illness in COVID-19. However, no specific targeting molecule has been identified for detecting or treating hyperinflammation related to dysregulated macrophages in severe COVID-19. In this study, previously published single-cell RNA-sequencing data of bronchoalv
    Document: The Coronavirus disease 2019 (COVID-19) has been spreading worldwide with rapidly increased number of deaths. Hyperinflammation mediated by dysregulated monocyte/macrophage function is considered to be the key factor that triggers severe illness in COVID-19. However, no specific targeting molecule has been identified for detecting or treating hyperinflammation related to dysregulated macrophages in severe COVID-19. In this study, previously published single-cell RNA-sequencing data of bronchoalveolar lavage fluid cells from thirteen COVID-19 patients were analyzed with publicly available databases for surface and imageable targets. Immune cell composition according to the severity was estimated with the clustering of gene expression data. Expression levels of imaging target molecules for inflammation were evaluated in macrophage clusters from single-cell RNA-sequencing data. In addition, candidate targetable molecules enriched in severe COVID-19 associated with hyperinflammation were filtered. We found that expression of SLC2A3, which can be imaged by [(18)F]fluorodeoxyglucose, was higher in macrophages from severe COVID-19 patients. Furthermore, by integrating the surface target and drug-target binding databases with RNA-sequencing data of severe COVID-19, we identified candidate surface and druggable targets including CCR1 and FPR1 for drug delivery as well as molecular imaging. Our results provide a resource in the development of specific imaging and therapy for COVID-19-related hyperinflammation.

    Search related documents:
    Co phrase search for related documents
    • accession number and lung tissue: 1
    • accession number and lymph lung: 1
    • additional study and low expression: 1
    • additional study and low quality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • low expression and lung immune cell: 1
    • low expression and lung inflammation: 1, 2, 3, 4, 5
    • low expression and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • low expression and lymph lung: 1
    • low expression show and lung tissue: 1
    • low quality and lung inflammation: 1, 2
    • low quality and lung tissue: 1, 2, 3, 4
    • lung immune cell and lymph lung: 1, 2, 3
    • lung inflammation and lymph lung: 1, 2, 3, 4, 5, 6
    • lung tissue and lymph lung: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25